Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06546332
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-06
Brief Title:
Post Market Clinical Follow-Up KeriFuse
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness and Safety of the KeriFuse Intramedullary Arthrodesis Implant and Associated Instruments in the Treatment of IP or DIP Arthritis a Post Market Clinical Follow-up
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The general objective of this study is to evaluate the performances and the safety related to the KeriFuse intramedullary arthrodesis implant and associated instrumentation used in accordance with their approved labelling and instruction for use Performance and safety of KeriFuse intramedullary arthrodesis implant will be established on short and middle-terms in regards to the implant life-cycle
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None